NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CellResearch Corporation

CellResearch Corporation

Private
SingaporeHealthcare & Life Scienceshttps://www.cellresearchcorp.com/

Last Round

Grant

Oct 13, 2021

Est. Valuation

$518M

Total Funding Raised

$14.8M

Company Overview

CellResearch Corporation is a biotechnology company that develops stem-cell-based research products and regenerative therapies derived from umbilical cord lining.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

stem cell bankingumbilical cord liningregenerative medicinecosmeceuticalscord tissue bankingbiotech licensingwound healingcell therapyskincare technologycontract researchcord blood bankingbiobankingaesthetic medicinecell strains

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CellResearch Corporation Comps

Public and private peers based on sector, stage, and business model.

CellResearch Corporation comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CellResearch Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 13, 2021
Convertible DebtFeb 1, 2016

Key People

Founding team and executive leadership

Thang Phan

Group Chief Scientific Officer, Founder Director

Founding Team

Gavin Tan

Group Chief Executive Officer

Executive Team

Paul Binney

Group Chief Financial Officer and Head of Global Distribution

Executive Team

Edwin Chow

Group Chief Operating Officer

Executive Team

CellResearch Corporation Investors

Notable investors and investment history

CellResearch Corporation investors
InvestorRounds
Government of SingaporeGrant
A*STARGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 21, 2023

    Grew 18% QoQ, from 17 to 20 employees.

CellResearch Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CellResearch Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CellResearch Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range22
Year Founded2002
Last FundingOct 13, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.